Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

RECOVERY, Collaborative Group; RECOVERY Collaborative Group; (2021) Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet (London, England), 397 (10285). pp. 1637-1645. ISSN 0140-6736 DOI: https://doi.org/10.1016/s0140-6736(21)00676-0

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1016/s0140-6736(21)00676-0

Abstract

Item Type Article
Research Centre Covid-19 Research
PubMed ID 33933206
Elements ID 168561

Share

Download

Filename: 1-s2.0-S0140673621006760-main.pdf

Licence: Creative Commons: Attribution 4.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar